Cosmax   Report issue

For profit
Founded: Bundang Korea, Republic of (1992)
Status: No NME R&D (1992)

Organization Overview

First Clinical Trial
2017
NCT03757611
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Nutribiotech Co., Ltd.

Active Ingredients

Drugs in Other Trials (1)

taheebo (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1